JOURNAL OF GASTROINTESTINAL ONCOLOGY, cilt.5, sa.4, ss.270-275, 2014 (ESCI)
Background: As a consequence of the improved survival due to the availability of several treatment option cost-effectiveness and health-related quality of life (HRQoL) issues have gained increasing attention in colorectal cancer (CRC). In the present study, we aimed to evaluate quality of life, level of anxiety and depression before and after a 6-month follow-up period in chemotherapy receiving patients with CRC.